| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 23.05.
| FDA approves extended use of Novo Nordisk Levemir insulin in children | | 11 | Pharma Bus Review |
| 18.05.
| Novo Nordisk Celebrates New INDYCAR Partnership Featuring Indy 500-Themed Billboard in Times Square | | 53 | Business Wire |
| Novo Nordisk, a world leader in diabetes care, announced today that it
has expanded its motorsports initiatives to include an official
partnership with INDYCAR. The healthcare...
Mehr lesen zu:
Novo Nordisk Celebrates New INDYCAR Partnership Featuring Indy 500-Themed Billboard in Times Square | |
| 15.05.
| Novo Nordisk Trading Lower Today on Above-Average Volume | | 9 | SmarTrend |
| 15.05.
| Research and License Agreements between National Cheng Kung University and Novo Nordisk A/S | | 44 | Business Wire |
| A southern Taiwan-based National Cheng Kung University (NCKU) research
team led by Ming-Shi Chang, NCKU professor of the Department of
Biochemistry and Molecular Biology...
Mehr lesen zu:
Research and License Agreements between National Cheng Kung University and Novo Nordisk A/S | |
| 14.05.
| Novo Nordisk Aktie: Empfehlenswert aber lieber noch warten! | | 83 | MoneyMoney |
| 11.05.
| Novo-Nordisk B (Denmark): Shares In Issue Update | | 13 | FTSE |
| 11.05.
| Novo-Nordisk B (Denmark): Shares In Issue Update (FTSEurofirst Series) | | 6 | FTSE |
| 11.05.
| Uptrend Call Working As Novo Nordisk Stock Rises 34.4% | | 8 | SmarTrend |
| 08.05.
| Novo Nordisk Inc. Appoints Robert Clark as Vice President, Regulatory Affairs | | 47 | PR Newswire |
| PRINCETON, N.J., May 8, 2012 /PRNewswire/ --Novo Nordisk Inc., a global healthcare company with 89 years of innovation and leadership in diabetes care, announced today that Robert Clark will be joining...
Mehr lesen zu:
Novo Nordisk Inc. Appoints Robert Clark as Vice President, Regulatory Affairs | |
| 04.05.
| Bearish Moving Average Cross by Novo Nordisk | | 9 | SmarTrend |
| 04.05.
| Novo Nordisk steps up research on diabetes | | 18 | Seattle Times |
| 01.05.
| Will Novo Nordisk Help You Retire Rich? | | 50 | Motley Fool |
| 01.05.
| Caisson Biotech Enters into Development and License Agreement with Novo Nordisk | | 84 | Business Wire |
| Caisson Biotech, L.L.C., a biopharmaceutical company with a patented
heparosan-based drug delivery technology, announced today that it has
entered into a Development and...
Mehr lesen zu:
Caisson Biotech Enters into Development and License Agreement with Novo Nordisk | |
| 27.04.
| Shares of Novo Nordisk Down on Above Average Volume, Moving Against Trend | | 30 | SmarTrend |
| 27.04.
| Novo Nordisk plans 15 percent expansion of U.S. work force in 2012 | | 68 | PR Newswire |
| PRINCETON, N.J., April 27, 2012 /PRNewswire/ --Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, today announced plans for a nearly...
Mehr lesen zu:
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012 | |
| 26.04.
| Novo Nordisk Honored as a Best Place to Work in New Jersey | | 11 | PR Newswire |
| PRINCETON, N.J., April 26, 2012 /PRNewswire/ --Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, was named as one of the "Best...
Mehr lesen zu:
Novo Nordisk Honored as a Best Place to Work in New Jersey | |
| 25.04.
| Novo Nordisk Crosses Above its 10-day MA | | 7 | SmarTrend |
| 23.04.
| Barclays Research senkt Novo Nordisk auf 'Underweight' - Ziel 753 Kronen | | 192 | APA-dpa-AFX-Analyser |
| Barclays Research hat die Einstufung von
Novo Nordisk von "Equal Weight" auf "Underweight" gesenkt, das
Kursziel aber von 710,00 auf 735,00 Dänische Kronen angehoben. Der
Wettbewerb um das hauseigene...
Mehr lesen zu:
Barclays Research senkt Novo Nordisk auf 'Underweight' - Ziel 753 Kronen | |
| 23.04.
| NASDAQ OMX Copenhagen A/S: Novo Nordisk A/S - reduction in share capital by cancelling own shares | | 43 | GlobeNewswire |
| The B share capital of the following share will be reduced on NASDAQ OMX
Copenhagen with effect from 25 April 2012.
On a general meeting in Novo Nordisk it was adopted to reduce the share capital
by...
Mehr lesen zu:
NASDAQ OMX Copenhagen A/S: Novo Nordisk A/S - reduction in share capital by cancelling own shares | |
| 20.04.
| MARKET PULSE-US stocks to watch: Novo Nordisk, Microsoft, Schlumberger | | 22 | Reuters.com |
